1887

Abstract

In a pilot study, the feasibility of immune whey protein concentrate (40 %; immune WPC-40) to aid the prevention of relapse of diarrhoea was evaluated. Immune WPC-40 was made from milk after immunization of Holstein–Frisian cows with inactivated toxins and killed whole-cell . Immune WPC-40 contained a high concentration of specific sIgA antibodies, and was effective in neutralizing the cytotoxic effect of toxins in cell assays . Immune WPC-40 conferred protection from otherwise lethal -associated caecitis in hamsters. To obtain preliminary data in humans, 16 patients (10 male; median 57 years) with toxin- and culture-confirmed diarrhoea were enrolled in an uncontrolled cohort study. Nine had a history of relapsing diarrhoea. After completion of standard antibiotic treatment, the patients received immune WPC-40 TID for 2 weeks; it was well tolerated and no treatment-related adverse effects were observed. In all but one case, toxins had disappeared from the faeces upon completion of treatment. During a follow-up period of median 333 days (range 35 days to 1 year), none of the patients had suffered another episode of diarrhoea. These preliminary data suggest that immune whey protein concentrate-40 may be of help in the prevention of relapse of diarrhoea.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.45773-0
2005-02-01
2019-11-22
Loading full text...

Full text loading...

/deliver/fulltext/jmm/54/2/JM540217.html?itemId=/content/journal/jmm/10.1099/jmm.0.45773-0&mimeType=html&fmt=ahah

References

  1. Aas, J., Gessert, C. E. & Bakken, J. S. ( 2003;). Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 36, 580–585.[CrossRef]
    [Google Scholar]
  2. Aspinall, S. T. & Hutchinson, D. N. ( 1992;). New selective medium for isolating Clostridium difficile from feces. J Clin Pathol 45, 812–814.[CrossRef]
    [Google Scholar]
  3. Barbut, F. & Petit, J.-C. ( 2001;). Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect 8, 405–411.
    [Google Scholar]
  4. Bennett, B. G., Gorbach, S. L., Goldin, B. R., Chang, T. W., Laughon, B. E., Greenough, W. B., III & Bartlett, J. G. ( 1996;). Treatment of relapsing Clostridium difficile diarrhoea with Lactobacillus GG. Nutrition Today 31 (Suppl), 35–38.[CrossRef]
    [Google Scholar]
  5. Bignardi, G. E. ( 1998;). Risk factors for Clostridium difficile infection. J Hospital Infect 40, 1–15.
    [Google Scholar]
  6. Burbige, E. J. & Milligan, F. D. ( 1975;). Pseudomembranous colitis.Association with antibiotics and therapy with cholestyramine. JAMA 231, 1157–1158.[CrossRef]
    [Google Scholar]
  7. Chang, T. W., Bartlett, J. G., Gorbach, S. L. & Onderdonk, A. B. ( 1978;). Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients. Infect Immun 20, 526–529.
    [Google Scholar]
  8. Fagarasan, S. & Honjo, T. ( 2003;). Intestinal IgA synthesis: regulation of front-line body defense. Nature Rev Immunol 3, 63–72.[CrossRef]
    [Google Scholar]
  9. Fedorko, D. P. & Williams, E. C. ( 1997;). Use of cycloserine-cefoxiton-fructose agar and l-prolin-aminopeptidase PRO discs in the rapid identification of Clostridium difficile. J Clin Microbiol 35, 1258–1259.
    [Google Scholar]
  10. Kelly, C. P., Pothoulakis, C. & Lamont, J. T. ( 1994;). Clostridium difficile colitis. N Engl J Med 330, 257–262.[CrossRef]
    [Google Scholar]
  11. Kelly, C. P., Pothoulakis, C., Vavva, F., Castagliuolo, I., Bostwick, E. F., O'Keane, J. C., Keates, S. & LaMont, J. T. ( 1996;). Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C.difficile toxins. Antimicrob Agents Chemother 40, 373–379.
    [Google Scholar]
  12. Kelly, C. P., Chetham, S., Keates, S., Bostwick, E. F., Roush, A. M., Castagliuolo, I., LaMont, J. T. & Pothoulakis, C. ( 1997;). Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract. Antimicrob Agents Chemother 41, 236–241.
    [Google Scholar]
  13. Kurtz, C. B., Cannon, E. P., Brezzani, A. & 12 other authors ( 2001;). GT160-246, a toxin binding polymer for treatment of Clostridium difficile colitis. Antimicrob Agents Chemother 45, 2340–2347.[CrossRef]
    [Google Scholar]
  14. Leung, D. Y., Kelly, C. P., Boguniewicz, M., Pothoulakis, C., LaMont, J. T. & Flores, A. ( 1991;). Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr 118, 633–637.[CrossRef]
    [Google Scholar]
  15. Lyerly, D. M., Bostwick, E. F., Binion, S. B. & Wilkins, T. D. ( 1991;). Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate. Infect Immun 59, 2215–2218.
    [Google Scholar]
  16. McFarland, L. V., Mulligan, M. E., Kwok, R. Y. Y. & Stamm, W. E. ( 1989;). Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 320, 204–210.[CrossRef]
    [Google Scholar]
  17. McFarland, L. V., Surawicz, C. M., Greenberg, R. N., Fekety, R., Elmer, G. W., Moyer, K. A., Melcher, S. A., Bowen, K. E., Cox, J. L. & Noorani, Z. ( 1994;). A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 271, 1913–1918.[CrossRef]
    [Google Scholar]
  18. McNulty, C., Logan, M., Donald, I. P., Ennis, D., Taylor, D., Baldwin, R. N., Bannerjee, M. & Cartwright, K. A. ( 1997;). Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. J Antimicrob Chemother 40, 707–711.[CrossRef]
    [Google Scholar]
  19. Minekus, M. & Havenaar, R. ( 1996). In Vitro Model of an In Vivo Digestive Tract. United States Patent, no. 5,525,305.
  20. Spencer, R. C. ( 1998;). Clinical impact and associated costs of Clostridium difficile-associated disease. J Antimicrob Chemother 41, 5–12.[CrossRef]
    [Google Scholar]
  21. Stoddart, B. & Wilcox, M. H. ( 2001;). Clostridium difficile. Curr Opin Infect Dis 15, 513–518.
    [Google Scholar]
  22. Sullivan, N. M., Pellett, S. & Wilkins, T. D. ( 1982;). Purification and characterization of Toxin A and B of Clostridium difficile. Infect Immun 35, 1032–1040.
    [Google Scholar]
  23. Surawicz, C. M., Elmer, G. W., Speelman, P., McFarland, L. V., Chinn, J. & van Belle, G. ( 1989;). Prevention of antibiotic-associated diarrhoea by Saccharomyces boulardii: a prospective study. Gastroenterology 96, 981–988.
    [Google Scholar]
  24. Taylor, N. S. & Bartlett, J. G. ( 1980;). Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins. J Infect Dis 141, 92–97.[CrossRef]
    [Google Scholar]
  25. Tedesco, F. J. ( 1982;). Treatment of recurrent antibiotic-associated pseudomembranous colitis. Am J Gastroenterol 77, 220–221.
    [Google Scholar]
  26. Thomas, M. R., Litin, S. C., Osmon, D. R., Corr, A. P., Weaver, A. L. & Lohse, C. M. ( 2001;). Lack of effect of Lactobacillus GG on antibiotic-associated diarrhoea: a randomized, placebo-controlled trial. Mayo Clin Proc 76, 883–889.[CrossRef]
    [Google Scholar]
  27. Warny, M., Fatimi, A., Bostwick, E. F., Laine, D. C., Lebel, F., LaMont, J. T., Pothoulakis, C. & Kelly, C. P. ( 1999;). Bovine immunoglobulin concentrate-Clostridium difficile retains C.difficile toxin neutralising activity after passage through the human stomach and small intestine. Gut 44, 212–217.[CrossRef]
    [Google Scholar]
  28. Wilcox, M. H., Cunniffe, J. G., Trundle, C. & Redpath, C. ( 1996;). Financial burden of hospital acquired Clostridium difficile infection. J Hosp Infect 34, 23–30.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.45773-0
Loading
/content/journal/jmm/10.1099/jmm.0.45773-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error